Brief: Janux Therapeutics Announces Submission Of Investigational New Drug Application For Janx008

Janux Therapeutics

27/12/2022 14:07

Dec 27 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS ANNOUNCES SUBMISSION OF INVESTIGATIONAL
NEW
DRUG APPLICATION FOR JANX008, AN EGFR-TRACTR FOR SOLID TUMORS

Source text for Eikon:  ID:nBw4jwF5Xa 
Further company coverage:  JANX.O 
 ((reuters.briefs@thomsonreuters.com;))